top of page
Executive Spotlights

Protaryx Medical Welcomes David Mester as New CEO to Spearhead Advancements

Baltimore, MD, September 12, 2023 (Business Wire) -- Protaryx Medical, announces, David Mester, MBA, as its newly appointed Chief Executive Officer (CEO). With a remarkable career spanning more than three decades in the structural heart medical device sector, Mester is poised to infuse Protaryx with his experience. Additionally, Protaryx is delighted to introduce Peter Boyd, J.D., MBA, as the latest addition to its distinguished board of directors.

Read full article here.

Recent Posts

See All

R3 Vascular Raises $87M in Series B Financing

Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in Series B financing. The funding round, spearheaded by Deerfield Ma


Life Science Headlines
bottom of page